Kymera Therapeutics, Inc.

General ticker "KYMR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.0B (TTM average)

Kymera Therapeutics, Inc. follows the US Stock Market performance with the rate: 44.8%.

Estimated limits based on current volatility of 6.7%: low 28.71$, high 32.82$

Factors to consider:

  • Price in estimated range
  • Earnings for 3 months up through Q1 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [22.55$, 50.71$]
  • 2025-12-31 to 2026-12-31 estimated range: [15.22$, 36.53$]

Financial Metrics affecting the KYMR estimates:

  • Negative: Non-GAAP EPS, $ of -2.97 <= 0.04
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -5.60 <= 1.79
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term KYMR quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-12202224262830323436
Price $

Long-term KYMR plot with estimates

10152025303540455055Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.8−0.6−0.4−0.20
KYMRS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $46.83MM $78.59MM $47.07MM
Operating Expenses $208.08MM $244.12MM $308.71MM
Operating Income $-161.26MM $-165.53MM $-261.63MM
Non-Operating Income $6.45MM $18.57MM $37.78MM
R&D Expense $164.25MM $189.08MM $240.25MM
Income(Loss) $-154.81MM $-146.96MM $-223.86MM
Profit(Loss)* $-151.83MM $-146.96MM $-223.86MM
Stockholders Equity $490.15MM $394.97MM $835.62MM
Inventory $12.25MM $0.00MM $0.00MM
Assets $603.13MM $575.76MM $978.03MM
Operating Cash Flow $-153.09MM $-102.83MM $-194.50MM
Capital expenditure $2.84MM $34.48MM $12.84MM
Investing Cash Flow $20.52MM $139.89MM $-404.08MM
Financing Cash Flow $153.00MM $4.19MM $608.85MM
Earnings Per Share** $-2.82 $-2.52 $-2.98

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.